* Prophase Labs Inc PRPH.OQ reported a quarterly adjusted
loss
of 51 cents per share for the quarter ended in December, lower
than the same quarter last year, when the company reported EPS
of -12 cents. The mean expectation of two analysts for the
quarter was for a loss of 26 cents per share. Wall Street
expected results to range from -27 cents to -25 cents per share.
* Revenue fell 80.1% to $4.35 million from a year ago;
analysts
expected $10.69 million.
* Prophase Labs Inc's reported EPS for the quarter was a
loss
of 51 cents.
* The company reported a quarterly loss of $8.75 million.
* Prophase Labs Inc shares had risen by 7.5% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Prophase
Labs Inc
is $15.50
This summary was machine generated from LSEG data March 15 at
01:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.26 -0.51 Missed
Sep. 30 2023 -0.19 -0.30 Missed
Jun. 30 2023 -0.14 -0.20 Missed
Mar. 31 2023 -0.10 0.03 Beat